important for regulating the function of synaptic AMPARs in hippocampal CA1 neurons. Introduction of a peptide corresponding to the last 11 amino acids of ct-GluR2/3 (pep2-SVKI) into CA1 neurons caused a potentiation of basal synaptic transmission in approximately onethird of cells. In addition, it blocked LTD in all cells tested. Application of a PKC inhibitor prevented both the potentiation in basal transmission and the blockade of LTD caused by pep2-SVKI. Prior induction of LTD resulted in pep2-SVKI causing a potentiation of EPSCs in the majority of cells. Furthermore, dedepression (i.e., repotentiation of a pathway that had previously received LTD) was selectively blocked by PKC inhibitors. These data indicate that the ct-GluR2/3 PDZ interactions regulate synaptic transmission at CA1 synapses in an activity-and PKC-dependent manner.
Results

Biochemical Investigation of the Effects of ct-GluR2 Peptides on the PICK1-GluR2 Interaction
To study the functional role(s) of ct-GluR2/3 PDZ interactions in synaptic transmission and long-term synaptic plasticity, we used a peptide corresponding to the last 11 amino acids of GluR2 (YNVYGIESVKI; We tested the effects of the 11-amino acid equivalents (b) Sequences of the synthetic peptides used in this study (single of these three peptides, pep2-SVKI, pep2-SVKE, and letter amino acid code) and the interactions that they block. pep2-
pep2-EVKI on the PICK1-GluR2 interaction (Figure 1).
SVKI is the sequence of the last 11 amino acids of wild-type GluR2.
Pep2-SVKI and pep2-EVKI blocked the retention of
Bold underlined residues indicate differences from the wild-type PICK1 by GST-GluR2, while pep2-SVKE had no effect.
GluR2 sequence.
Thus, pep2-SVKE is an ideal control peptide for testing ct-GluR2 PDZ interactions, and pep2-EVKI, in agreement with another recent study (Chung et and persisted for the duration of recordings (up to 90 min). In the remaining pathways (63/99, 64%), no change in EPSC amplitude was observed for the duration of
Pep2-SVKI Causes an Increase in the Amplitude of AMPAR-Mediated EPSCs in a Subset
recordings (up to 100 min; Figure 2b ). This increase in EPSC amplitude in a subset of experiments was consisof Experiments To study the role of ct-GluR2/3 PDZ interactions in regutently observed with different batches of pep2-SVKI and by different investigators. When all data were pooled lating synaptic AMPARs, we introduced ct-GluR2 peptides into CA1 pyramidal cells in hippocampal slices via (increase and no increase in EPSC amplitude) there was a significant increase in EPSC amplitude at 25-30 min the patch electrode during whole-cell recordings. In a first set of experiments, we studied the effects on basal compared to the first 5 min of recordings (EPSC amplitude ϭ 134% Ϯ 7%, p Ͻ 5 ϫ 10 Ϫ4 , n ϭ 99; Figure 2c ). synaptic transmission by infusing peptides into neurons while evoking AMPAR-mediated excitatory postsynapWe also separated and pooled the data on the basis of whether there was an increase in amplitude (Figure 2d ). tic currents (EPSCs). In the majority of experiments two independent pathways were stimulated. When using an EPSC amplitude increased to 205% Ϯ 15% (p Ͻ 1 ϫ 10 Ϫ5 , n ϭ 36) in the subset that exhibited the increase, intracellular solution containing pep2-SVKI (100 M), an increase in the amplitude of EPSCs was observed ‫5ف‬ while amplitude exhibited a small depression in the remainder (93% Ϯ 2%, p Ͻ 0.05, n ϭ 63). min after the start of the recording in 36/99 (36%) pathways (EPSC amplitude average over a 5 min period from This effect of pep2-SVKI on EPSC amplitude was pre- dominantly cell rather than pathway specific (Figure 2e) . rupted the interaction between ct-GluR2 and PDZ proteins, the change in quantal content was very likely due In the majority of cells in which data from two pathways were collected, pep2-SVKI had the same effect on both to a postsynaptic increase in the number of functional synapses. One possibility, therefore, is that pep2-SVKI pathways (in 11/38 cells [29%] both pathways increased, in 21/38 cells [55%] there was no effect), while causes the insertion of AMPARs at silent synapses producing a postsynaptic increase in n. in only 6/38 cells (16%) the effects were pathway specific.
We also performed two types of controls, interleaved with the pep2-SVKI experiments. In one set of experiWe also performed a coefficient of variation (CV) analysis (Faber and Korn, 1991; Kullmann, 1994) on 11 of ments, an intracellular solution that lacked pep2-SVKI, but was otherwise identical, was used (Figures 3a and the pathways that exhibited the increase with pep2-SVKI. This analysis showed that on average there was 3b). In the other controls, the inactive control peptide pep2-SVKE was used (Figures 3c and 3d ). There was a large change in CV associated with the increase in amplitude. When change in 1/CV 2 was plotted versus no change in EPSC amplitude in the "no peptide" control (107% Ϯ 5%, p ϭ 0.1, n ϭ 51) or in the presence of change in EPSC amplitude, the mean value was very close to the line of unity (1/CV 2 ϭ 194% Ϯ 22%; EPSC pep2-SVKE (103% Ϯ 5%, p ϭ 0.3, n ϭ 44). Pep2-SVKI does not distinguish between the GRIP/ amplitude ϭ 186% Ϯ 16% n ϭ 11; Figure 2f ), indicating that the increase in EPSC amplitude was most likely ABP-GluR2 and PICK1-GluR2 interactions. To investigate which interacting protein was important for this due to a change in quantal content. Quantal content is composed of probability of release (Pr) and number of effect, we used pep2-EVKI, which blocks PICK1 but not GRIP/ABP binding to GluR2 tential recordings. Neither inhibitor had any effect on basal transmission in these experiments (data not is not involved in this regulation of AMPARs and that rather it is the GRIP/ABP-GluR2/3 interaction that is shown). These data suggest that during basal transmission AMPAR function at these synapses is not mainimportant. Alternatively, it could mean that the GRIP/ ABP and PICK1 are both involved but that they are tained by constitutive PKC activity. This is in agreement with other studies in which it was found that inhibitors interchangeable.
acting is required for the block of LTD to occur when ct-GluR2/3 PDZ interactions are disrupted by pep2-SVKI. The effect of pep2-SVKI on LTD was independent of whether or not it caused an increase in basal EPSC amplitude. Importantly, the control peptide pep2-SVKE Prior Induction of LTD Modifies the Effects of Pep2-SVKI on Basal Transmission did not block LTD (73% Ϯ 9%, p Ͻ 0.05 versus pre-LTD baseline, n ϭ 10; Figure 5b ). We also tested whether
We reasoned that the block of LTD by pep2-SVKI might be because LTD primes synapses to undergo the inpep2-EVKI, which selectively blocks the PICK1 interaction, prevented LTD. In the presence of pep2-EVKI, LTD crease in transmission in the presence of the peptide. To test this idea, we performed two pathway experiments was also reliably induced (81% Ϯ 3%, p Ͻ 0.001 versus pre-LTD baseline, n ϭ 8; Figure 5b) . Thus, pep2-SVKI, using extracellular recordings in which LTD was induced in one pathway by applying a low-frequency stimulation but neither pep2-SVKE nor pep2-EVKI, blocked LTD. However, unlike with basal transmission, pep2-SVKI protocol (LFS; 900 stimuli, 1Hz; Figure 6a ). This pro- duced a homosynaptic depression in fEPSP slope to increase in amplitude in the majority of experiments. The lack of pathway specificity of this particular effect 71% Ϯ 4% of baseline (n ϭ 8). After induction of LTD, a whole-cell recording was obtained from a neuron in suggests that the induction of LTD causes the production of some signal that can diffuse to other noncondithe same region of the slice, and EPSCs were evoked at the same two pathways using the same or lower tioned synapses causing the heterosynaptic effects. Prior induction of LTD also had another effect. The stimulus intensity. Under these conditions, the frequency with which pep2-SVKI caused an increase in onset of the increase in EPSC amplitude caused by pep2-SVKI was much more rapid following LTD inductransmission was greatly increased (Figures 6b-6d) . Surprisingly, this effect was not restricted to the pathtion, compared to nonconditioned slices that showed a characteristic onset delay of ‫5ف‬ min (Figure 6c ). This way that had previously received LTD, but occurred in both the conditioned and nonconditioned pathways.
suggests that prior induction of LTD (i.e., in the absence of pep2-SVKI) primes synapses both homo-and heteroSince these experiments were performed at a higher temperature to facilitate the induction of LTD using LFS synaptically so that subsequent disruption of the ctGluR2 PDZ interactions causes a very rapid insertion of (28ЊC-30ЊC rather than room temperature), we also tested the effect of pep2-SVKI at this temperature on receptors. slices in which LTD had not been induced ("nonconditioned" slices). Similar to experiments performed at A Model for the Regulation of AMPAR Insertion by ct-GluR2 PDZ Interactions room temperature, pep2-SVKI caused an increase in EPSC amplitude only in a subset of experiments ( Figures  Figure 7 shows a hypothesis based on the data presented so far, for the mechanism by which ct-GluR2/3 6c and 6d), although the kinetics of the increase exhibited a somewhat different profile, presumably due to PDZ interactions regulate AMPARs at CA1 synapses. In this model, there are two intracellular pools of AMPARs the higher temperature. These data suggest that prior induction of LTD primes synapses or receptors so that at synapses: AMPARs containing GluR2 phosphorylated at serine 880 in a "constitutive pool," which rapidly and disruption of the ct-GluR2 PDZ interactions causes an viously undergone LTD (Figure 8a) . DD, however, was Figures 8b and 8c) .
Since a single amino acid substitution (-SVKI to -SVKE) renders the peptide inactive at blocking both PICK1 Therefore, these data show that DD is PKC dependent and suggests that the ct-GluR2 PDZ interactions can ( sequence to pep2-SVKI. Furthermore, Hayashi and coFollowing prior induction of LTD, pep2-SVKI caused an workers found that the GluR1 PDZ interaction was necincrease in basal transmission at both conditioned and essary for insertion, and therefore if blocked this would control pathways in most experiments. Finally, we demcause a depression in EPSC amplitude, contrary to the onstrated that DD was blocked by PKC inhibitors. We results in the present study. propose a model in which ct-GluR2 PDZ proteins are One potential problem with the peptides used in this involved in the expression of LTD. In addition, we prostudy is that there is a possibility that they could act as pose that these interactions are involved in a form of competitive inhibitors of PKC. However, in our study all LTP, by regulating the PKC-dependent insertion of the effects of pep2-SVKI were blocked by a PKC inhibiAMPARs so that DD can be triggered by an appropriate tor, strongly suggesting that pep2-SVKI was not itself physiological stimulus.
acting as a PKC inhibitor. Furthermore, the effects of the ten amino acid ct-GluR2 peptides on AMPARs in Specificity of the Interaction spinal cord neurons have been shown not to be due Using a biochemical assay, we have shown that pep2-to direct inhibition of PKC (Li et al., 1999) . A related SVKI blocks the PICK1-GluR2 interaction, and in a previous study an almost identical peptide, "GluR2-SVKI," consideration is that pep2-SVKI needs to be phosphory- . The finding that the increase in basal transmission with pep2-SVKI is associated with a large GluR2. Although we cannot completely exclude this possibility, evidence against this is provided by the lack of change in CV is consistent with this possibility and indicates that receptors may be preferentially inserted at effect of pep2-EVKI in which the serine is substituted by a glutamate, a manipulation equivalent to the phossilent synapses. One surprising finding was that the effects of pep2-phorylation of serine 880 (at least with respect to preventing the interaction between GRIP/ABP and GluR2).
SVKI were primarily cell specific rather than pathway specific. Further evidence for a cell-specific effect was provided by the experiments in which LTD was induced Functional Effects of Pep2-SVKI prior to introducing the peptide into cells. Under these on AMPAR-Mediated EPSCs conditions, the incidence of the increase in transmission There are a number of possible mechanisms by which with pep2-SVKI was greatly increased, but this occurred pep2-SVKI could cause the enhancement of synaptic at both the LTD and control pathways. This suggests transmission. Given that we use a postsynaptically inthat some signal is generated at the synapses that unjected peptide, it is highly unlikely that the effects are derwent LTD, which diffuses intracellularly to other synpresynaptic or via glutamate transporter mechanisms. 
